A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

The TSX parent reported adjusted earnings per share of 48 cents, topping the Street’s expectation by 4 cents as organic ...

Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

Tesla lost market share in Sweden and Norway in January, car registration data showed on Monday as the U.S. electric vehicle ...

Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this ...

The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...

Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million.

"We are inspired to work with Pfizer to fight the devastating impacts of COVID-19 and other health conditions ... Roche gets the first FDA approval for a diagnostic test for HER2-ultralow ...

An international team of researchers, led by scientists from Tel Aviv University, has discovered that the pathogen ...

There are growing concerns about the worldwide expansion of coral reef destruction. Research team: “This is an extremely ...